Desiree Hunt Floyd
, Charlottesville

Cancer Research

Ph.D.
28.46

Topics(6)

Awards and achievements (1)

  • Jan 2006
    Ruth L. Kirschstein NRSA F32 Postdoctoral Institutional Training Grant
    Grant

About

My most exciting current research involves re-purposing an orphan drug that is directly cytotoxic to cancer, is orally bioavailable, can cross the BBB, has long serum half-life, has been shown to be safe in humans, and displays synergistic survival benefits when used in combination the Glioblastoma standard of care.

Skills and expertise(30) View all